{"product_id":"biotinylated-cd19-hisavi-tag-protein-human-ua016135","title":"Biotinylated CD19 His\u0026Avi Tag Protein, Human","description":"\u003ch4\u003eProduct Specification\u003c\/h4\u003e\u003cdiv class=\"responsive-table product-detail-table details-table\"\u003e\n\u003cbr\u003e\u003ctable style=\"width: 100%; height: auto;\"\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eSpecies\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eHuman\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eSynonyms\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eB4, CVID3, MGC12802\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eAccession\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eP15391-1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eAmino Acid Sequence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\u003cp\u003ePro20-Lys291 with His\u0026amp;Avi Tag at the C-Terminus\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eExpression System\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eHEK293\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e50-70kDa (Reducing)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e＞95% by SDS-PAGE\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eConjugation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eBiotin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eTag\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eAvi Tag, His Tag\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003ePhysical Appearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003eLyophilized Powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eStorage Buffer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\u003cp\u003ePBS, pH7.4, 5% trehalose\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\u003cp\u003e\u003cspan\u003eReconstitute at 0.1-1 mg\/ml according to the size in ultrapure water after rapid centrifugation.\u003c\/span\u003e\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eStability \u0026amp; Storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\n\u003cp\u003e\u003cspan\u003e· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e· 3 months, -20 to -80℃ under sterile conditions after reconstitution.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e· 1 week, 2 to 8℃ under sterile conditions after reconstitution.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e· Please avoid repeated freeze-thaw cycles.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 22%;\"\u003e\u003cstrong\u003eReference\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd style=\"width: 78%;\"\u003e\u003cp\u003e1. MÜLLER F, ATREYA R, VÖLKL S, et al. CD19 CAR T-cell therapy in multidrug-resistant ulcerative colitis[J]. New England Journal of Medicine, 2025, 393(12): 1239-1241. \u003cbr\u003e2. YANG C, SUN C, TAN B, et al. Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus[J]. Cell Research, 2025, 35(8): 607-609.\u003cbr\u003e3. CHU Y, ZHOU B, GAO R, et al. Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab[J]. Blood Cancer Journal, 2025, 15: 11.\u003cbr\u003e4. ZUGASTI I, et al. CAR-T cell therapy for cancer: current challenges and next-generation strategies[J]. Signal Transduction and Targeted Therapy, 2025, 10(1): 51.\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\n\u003c\/div\u003e\u003ch4\u003eBackground\u003c\/h4\u003e\u003cdiv\u003e\u003cp\u003e\u003cspan\u003eCD19, also known as B-lymphocyte antigen CD19 or B4, is a type I transmembrane glycoprotein belonging to the immunoglobulin superfamily. Its structure comprises an extracellular region containing two immunoglobulin-like domains (one V-type and one C2-type), a transmembrane domain, and a cytoplasmic tail harboring multiple tyrosine phosphorylation sites that interact with Src family kinases (such as Lyn and Fyn) and PI3K signaling molecules. CD19 is specifically expressed throughout the B-lymphocyte lineage, from the pre-B cell stage through mature B cells, though it is downregulated at the plasma cell stage, serving as a critical co-stimulatory molecule for B cell activation, proliferation, and differentiation. Functionally, CD19 lowers the signaling threshold of the B cell receptor (BCR), enhancing the sensitivity of B cell responses to antigens, while also participating in B cell development, antibody class switching, and germinal center reactions. In recent years, CD19 has emerged as one of the most successful targets in tumor immunotherapy, with chimeric antigen receptor T cell (CAR-T) therapy directed against CD19 achieving breakthrough efficacy in B cell acute lymphoblastic leukemia (B-ALL) and diffuse large B cell lymphoma (DLBCL), and further expanding into the treatment of autoimmune diseases such as systemic lupus erythematosus and ulcerative colitis, demonstrating broad clinical application prospects.\u003c\/span\u003e\u003c\/p\u003e\u003c\/div\u003e","brand":"UA BIOSCIENCE","offers":[{"title":"25μg","offer_id":42887927365707,"sku":"UA016135-25μg","price":430.0,"currency_code":"USD","in_stock":true},{"title":"100μg","offer_id":42887927398475,"sku":"UA016135-100μg","price":850.0,"currency_code":"USD","in_stock":true},{"title":"500μg","offer_id":42887927431243,"sku":"UA016135-500μg","price":2240.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0590\/8375\/1499\/files\/AntBioImage_d28d0e48-05ca-469f-afc3-6727828eac92.png?v=1783774836","url":"https:\/\/www.antbioinc.com\/products\/biotinylated-cd19-hisavi-tag-protein-human-ua016135","provider":"AntBio","version":"1.0","type":"link"}